BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 8547632)

  • 21. Simultaneous antagonism of interleukin-5, granulocyte-macrophage colony-stimulating factor, and interleukin-3 stimulation of human eosinophils by targetting the common cytokine binding site of their receptors.
    Sun Q; Jones K; McClure B; Cambareri B; Zacharakis B; Iversen PO; Stomski F; Woodcock JM; Bagley CJ; D'Andrea R; Lopez AF
    Blood; 1999 Sep; 94(6):1943-51. PubMed ID: 10477723
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mapping of human granulocyte-macrophage-colony-stimulating-factor domains interacting with the human granulocyte-macrophage-colony-stimulating-factor-receptor alpha-subunit.
    Brown CB; Pihl CE; Kaushansky K
    Eur J Biochem; 1994 Nov; 225(3):873-80. PubMed ID: 7957224
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Roles of the N and C terminal domains of the interleukin-3 receptor alpha chain in receptor function.
    Barry SC; Korpelainen E; Sun Q; Stomski FC; Moretti PA; Wakao H; D'Andrea RJ; Vadas MA; Lopez AF; Goodall GJ
    Blood; 1997 Feb; 89(3):842-52. PubMed ID: 9028315
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Two modes of beta-receptor recognition are mediated by distinct epitopes on mouse and human interleukin-3.
    Mirza S; Chen J; Wen B; Ewens CL; Dai J; Murphy JM; Young IG
    J Biol Chem; 2010 Jul; 285(29):22370-81. PubMed ID: 20472554
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A model for assembly and activation of the GM-CSF, IL-3 and IL-5 receptors: insights from activated mutants of the common beta subunit.
    D'Andrea RJ; Gonda TJ
    Exp Hematol; 2000 Mar; 28(3):231-43. PubMed ID: 10720688
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification of a Cys motif in the common beta chain of the interleukin 3, granulocyte-macrophage colony-stimulating factor, and interleukin 5 receptors essential for disulfide-linked receptor heterodimerization and activation of all three receptors.
    Stomski FC; Woodcock JM; Zacharakis B; Bagley CJ; Sun Q; Lopez AF
    J Biol Chem; 1998 Jan; 273(2):1192-9. PubMed ID: 9422786
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A cell type-specific constitutive point mutant of the common beta-subunit of the human granulocyte-macrophage colony-stimulating factor (GM-CSF), interleukin (IL)-3, and IL-5 receptors requires the GM-CSF receptor alpha-subunit for activation.
    Jenkins BJ; Le F; Gonda TJ
    J Biol Chem; 1999 Mar; 274(13):8669-77. PubMed ID: 10085105
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Interleukin-3 (IL-3) and granulocyte-macrophage colony-stimulating factor (GM-CSF) can induce differentiation of chronic B cell leukemia expressing the alpha subunit of IL-3 and GM-CSF receptor.
    Shiiba M; Takaki S; Takatsu K
    Int Arch Allergy Immunol; 1996; 111 Suppl 1():12-5. PubMed ID: 8906104
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Functional reconstitution of the human interleukin-3 receptor.
    Kitamura T; Miyajima A
    Blood; 1992 Jul; 80(1):84-90. PubMed ID: 1377056
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clarification of the role of N-glycans on the common beta-subunit of the human IL-3, IL-5 and GM-CSF receptors and the murine IL-3 beta-receptor in ligand-binding and receptor activation.
    Murphy JM; Soboleva TA; Mirza S; Ford SC; Olsen JE; Chen J; Young IG
    Cytokine; 2008 May; 42(2):234-242. PubMed ID: 18374598
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Reciprocal inhibition of binding between interleukin 3 and granulocyte-macrophage colony-stimulating factor to human eosinophils.
    Lopez AF; Eglinton JM; Gillis D; Park LS; Clark S; Vadas MA
    Proc Natl Acad Sci U S A; 1989 Sep; 86(18):7022-6. PubMed ID: 2550928
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hematopoiesis in mice lacking the entire granulocyte-macrophage colony-stimulating factor/interleukin-3/interleukin-5 functions.
    Nishinakamura R; Miyajima A; Mee PJ; Tybulewicz VL; Murray R
    Blood; 1996 Oct; 88(7):2458-64. PubMed ID: 8839836
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Monoclonal antibodies specific for low-affinity interleukin-3 (IL-3) binding protein AIC2A: evidence that AIC2A is a component of a high-affinity IL-3 receptor.
    Ogorochi T; Hara T; Wang HM; Maruyama K; Miyajima A
    Blood; 1992 Feb; 79(4):895-903. PubMed ID: 1737099
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Transcription of genes encoding granulocyte-macrophage colony-stimulating factor, interleukin 3, and interleukin 6 receptors and lack of proliferative response to exogenous cytokines in nonhematopoietic human malignant cell lines.
    Guillaume T; Sekhavat M; Rubinstein DB; Hamdan O; Symann ML
    Cancer Res; 1993 Jul; 53(13):3139-44. PubMed ID: 8319222
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Interaction of GM-CSF and IL-3 with the common beta-chain of their receptors.
    Bagley CJ; Woodcock JM; Hercus TR; Shannon MF; Lopez AF
    J Leukoc Biol; 1995 May; 57(5):739-46. PubMed ID: 7759954
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Modulation of myeloid proliferation and differentiation by monoclonal antibodies directed against a protein that interacts with the interleukin-3 receptor.
    Tweardy DJ; Morel PA; Mott PL; Glazer EW; Zeh HJ; Sakurai M
    Blood; 1992 Jul; 80(2):359-66. PubMed ID: 1378315
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bivalent binding and signaling characteristics of Leridistim, a novel chimeric dual agonist of interleukin-3 and granulocyte colony-stimulating factor receptors.
    Monahan JB; Hood WF; Welply JK; Shieh JJ; Polazzi JO; Li X
    Exp Hematol; 2001 Apr; 29(4):416-24. PubMed ID: 11301181
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A model for the interaction of the GM-CSF, IL-3 and IL-5 receptors with their ligands.
    Goodall GJ; Bagley CJ; Vadas MA; Lopez AF
    Growth Factors; 1993; 8(2):87-97. PubMed ID: 8466757
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Common binding structure for granulocyte macrophage colony-stimulating factor and interleukin-3 on human acute myeloid leukemia cells and monocytes.
    Budel LM; Elbaz O; Hoogerbrugge H; Delwel R; Mahmoud LA; Löwenberg B; Touw IP
    Blood; 1990 Apr; 75(7):1439-45. PubMed ID: 2156580
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Novel murine myeloid cell lines that exhibit a differentiation switch in response to IL-3 or GM-CSF, or to different constitutively active mutants of the GM-CSF receptor beta subunit.
    McCormack MP; Gonda TJ
    Blood; 2000 Jan; 95(1):120-7. PubMed ID: 10607694
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.